Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer
Sharon H. Giordano(The University of Texas MD Anderson Cancer Center), James S. Goodwin(John Sealy Hospital), Gabriel N. Hortobágyi(The University of Texas MD Anderson Cancer Center), Yong‐Fang Kuo(John Sealy Hospital), Zhigang Duan(The University of Texas MD Anderson Cancer Center)
Cited by 327
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
Risk of Fracture after Androgen Deprivation for Prostate Cancer
|New England Journal of Medicine|2005|1.4k
Effect of aging on respiratory system physiology and immunology
|Clinical Interventions in Aging|2006|1k
Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.
|The Journal of Experimental Medicine|1977|795
Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer
|Journal of Clinical Oncology|2007|630